<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction extraction-result-113 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extracted Data Details for extraction-result-113</h1>

        <div class="section">
            <h2>Extracted Data (Header)</h2>
            <div class="info-section">
                <p><strong>Extraction ID:</strong> extraction-result-113</p>
                <p><strong>Extraction Schema Used (ID):</strong> <a href="../schemas/extraction-schema-1.html">extraction-schema-1</a></p>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in lung cancer across different ethnic or ancestral populations, particularly comparing East Asian patients to other populations, including environmental factors, genetic background, and proposed mechanisms for population differences.</div>
                <p><strong>Paper ID:</strong> paper-1050546</p>
                <p><strong>Paper Title:</strong> Prevalence of EGFR Mutations in Lung Cancer in Uruguayan Population</p>
                <p><strong>Paper Abstract:</strong> Background Incorporation of molecular analysis of the epidermal growth factor receptor (EGFR) gene into routine clinical practice represents a milestone for personalized therapy of the non-small-cell lung cancer (NSCLC). However, the genetic testing of EGFR mutations has not yet become a routine clinical practice in developing countries. In view of different prevalence of such mutations among different ethnicities and geographic regions, as well as the limited existing data from Latin America, our aim was to study the frequency of major types of activating mutations of the EGFR gene in NSCLC patients from Uruguay. Methods We examined EGFR mutations in exons 18 through 21 in 289 NSCLC Uruguayan patients by PCR-direct sequencing. Results EGFR mutations were detected in 53 of the 289 (18.3%) patients, more frequently in women (23.4%) than in men (14.5%). The distribution by exon was similar to that generally reported in the literature. Conclusions This first epidemiological study of EGFR mutations in Uruguay reveals a wide spectrum of mutations and an overall prevalence of 18.3%. The background ethnic structure of the Uruguayan population could play an important role in explaining our findings.</p>
                <p><strong>Cost:</strong> 0.022</p>
            </div>
        </div>

        <div class="section">
            <h2>Extracted Data (Details)</h2>
            <div class="extraction-instance-container" id="e113.0">
                <h3 class="extraction-instance">Extracted Data Instance 0 (e113.0)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in lung cancer across different ethnic or ancestral populations, particularly comparing East Asian patients to other populations, including environmental factors, genetic background, and proposed mechanisms for population differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Uruguayans (this study)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Uruguayan NSCLC patients (this study)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Prospective molecular epidemiology study of EGFR exons 18-21 in 289 Uruguayan NSCLC cases (enriched for adenocarcinomatous differentiation) using nested PCR and Sanger sequencing; reports overall EGFR mutation prevalence and mutation spectrum with ancestry context.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>here</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>289 NSCLC patients from Uruguay (samples referred from public and private hospitals countrywide between Jan 2012 and Apr 2017); inclusion: tumors with adenocarcinomatous differentiation or not excluded.</td>
                        </tr>
                        <tr>
                            <td><strong>population_ancestry</strong></td>
                            <td>Admixed Uruguayan population with predominant European origin; reported genetic contributions ~European major component, Native American ~10.4%, African ~5.6% (paper cites admixture studies).</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td>18.3% (53/289 patients had at least one EGFR mutation).</td>
                        </tr>
                        <tr>
                            <td><strong>specific_egfr_mutations</strong></td>
                            <td>Total 59 mutations (4 patients had multiple): exon 19 deletions 30/59 (50.8% of mutations), L858R (exon 21) 13/59 (22.0%), exon 18 mutations 6/59 (10.2%), exon 20 mutations 5/59 (8.5%); notable uncommon mutations: p.G719C, p.E709X (exon 18), p.K714N/E, p.L861Q, p.S768I, p.P848L, p.A840T; resistance mutation T790M found twice (one de novo, one post-TKI).</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_smoking_association</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td>None specifically measured or reported for Uruguayan cohort; authors note inability to collect clinicopathologic data (including smoking) because samples came from multiple institutions.</td>
                        </tr>
                        <tr>
                            <td><strong>germline_genetic_factors</strong></td>
                            <td>Observed coding silent polymorphism c.2361G>A (p.Q787Q) with G allele frequency ~0.405 in this cohort; no significant association with L858R or exon 19 deletions was found in this study.</td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td>Compared qualitatively to published frequencies in Asians (much higher) and Europeans (lower); authors place the Uruguayan rate (18.3%) between typical European and many Latin American reported values.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Authors propose that the admixed ethnic background (mixture of European, Native American, and African ancestry) of Uruguayans influences EGFR mutation prevalence; Amerindian genomic contribution is suggested as a potential factor elevating prevalence above typical European rates.</td>
                        </tr>
                        <tr>
                            <td><strong>clinical_characteristics</strong></td>
                            <td>All samples had adenocarcinomatous component or could not exclude adenocarcinoma; EGFR mutations were more frequently observed in women (23.4% in women vs 14.5% in men in this cohort).</td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td>No clinical covariates (e.g., smoking, stage) were available; sample referral bias possible; technical amplification failures in ~8% of submissions; authors acknowledge population admixture and lack of clinical data as limitations.</td>
                        </tr>
                        <tr>
                            <td><strong>geographic_variation</strong></td>
                            <td>Single-country (Uruguay) data; authors contrast Uruguay with other Latin American countries and global populations to discuss geographic/ancestral differences.</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e113.1">
                <h3 class="extraction-instance">Extracted Data Instance 1 (e113.1)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in lung cancer across different ethnic or ancestral populations, particularly comparing East Asian patients to other populations, including environmental factors, genetic background, and proposed mechanisms for population differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>East Asian</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>East Asian patients (pooled literature reports / consensus)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Multiple studies and consensus statements report substantially higher EGFR mutation prevalence in East Asian NSCLC patients compared with other ethnic groups.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>The international association for the study of lung cancer consensus statement on optimizing management of EGFR mutation-positive non-small cell lung cancer: status in 2016.</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>Pooled East Asian patients across multiple published studies (no single cohort given in this paper); figures reported in global reviews/consensus.</td>
                        </tr>
                        <tr>
                            <td><strong>population_ancestry</strong></td>
                            <td>East Asian (broad category referenced in consensus and multiple cited regional studies).</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td>Reported as 'around 60%' in the introduction (consensus citation); elsewhere in the discussion authors cite Asian prevalence in the 50-60% range when contrasting with Caucasians.</td>
                        </tr>
                        <tr>
                            <td><strong>specific_egfr_mutations</strong></td>
                            <td>Authors state the two most common EGFR activating mutations (exon 19 deletions and exon 21 L858R) predominate across populations; no Asia-specific mutation breakdown provided in this paper.</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_smoking_association</strong></td>
                            <td>EGFR mutations are often associated with non-tobacco exposure in the general literature (not quantified for East Asians in this paper).</td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td>Not specified for East Asian populations in this paper (general statement links EGFR mutations with nontobacco exposure).</td>
                        </tr>
                        <tr>
                            <td><strong>germline_genetic_factors</strong></td>
                            <td>Paper implies population genetic background (ancestry) underlies higher East Asian prevalence but does not list specific germline risk variants for East Asians other than population-level polymorphism frequency differences (e.g., Q787Q distribution differences cited).</td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td>Contrasted repeatedly with Caucasian/European prevalence (~10-17%) and Latin American heterogeneity; East Asian rates cited as much higher (~50-60% vs 10-17% in Caucasians).</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Authors and cited consensus suggest genetic susceptibility related to ancestral background (population genetics) and associations with clinical features (adenocarcinoma histology, never-smoker status) as explanations for higher prevalence in East Asians.</td>
                        </tr>
                        <tr>
                            <td><strong>clinical_characteristics</strong></td>
                            <td>In literature, EGFR mutations in East Asians correlate with adenocarcinoma histology, female sex, and never-/light-smoking status (paper cites these general associations).</td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td>Paper cautions cross-study comparisons due to differing detection methods, selection biases, and study designs (these issues apply to East Asian data as well).</td>
                        </tr>
                        <tr>
                            <td><strong>geographic_variation</strong></td>
                            <td>East Asia (broad) reported as region with highest frequencies; no intra-East-Asia breakdown presented here.</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e113.2">
                <h3 class="extraction-instance">Extracted Data Instance 2 (e113.2)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in lung cancer across different ethnic or ancestral populations, particularly comparing East Asian patients to other populations, including environmental factors, genetic background, and proposed mechanisms for population differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Caucasian/European</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Caucasian / European NSCLC patients (pooled literature)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Multiple European/Caucasian cohorts show markedly lower prevalence of EGFR activating mutations compared with East Asian cohorts, as summarized in the literature and cited reviews.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>The international association for the study of lung cancer consensus statement on optimizing management of EGFR mutation-positive non-small cell lung cancer: status in 2016.</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>Pooled Caucasian / European patients across multiple studies cited by the authors; no single cohort from this paper except comparisons to European reports.</td>
                        </tr>
                        <tr>
                            <td><strong>population_ancestry</strong></td>
                            <td>European / Caucasian.</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td>Reported in-text as roughly 10-15% (also stated elsewhere as 10-17% in Caucasians).</td>
                        </tr>
                        <tr>
                            <td><strong>specific_egfr_mutations</strong></td>
                            <td>Exon 19 deletions and L858R are the dominant mutations also in Caucasian populations; exact distribution not detailed here.</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_smoking_association</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td>Not specified for European populations in this paper.</td>
                        </tr>
                        <tr>
                            <td><strong>germline_genetic_factors</strong></td>
                            <td>Authors imply lower prevalence is related to different ancestral genetic background compared with East Asians; no specific germline variants are proposed for Europeans in this paper.</td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td>Directly contrasted to East Asian prevalence (~50-60% vs ~10-17% in Caucasians).</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Authors suggest population genetic differences (ancestry) as the major explanation; testing method differences and clinical selection biases are also noted as potential contributors.</td>
                        </tr>
                        <tr>
                            <td><strong>clinical_characteristics</strong></td>
                            <td>Not specifically detailed in this paper for Europeans; general statements about associations of EGFR mutations with adenocarcinoma and never-smoker status apply across groups.</td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td>Differences in study methods, selection biases, and limited representation in some cohorts may confound comparisons.</td>
                        </tr>
                        <tr>
                            <td><strong>geographic_variation</strong></td>
                            <td>Europe / Caucasian populations show lower EGFR mutation frequencies compared to East Asian and some Latin American populations.</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e113.3">
                <h3 class="extraction-instance">Extracted Data Instance 3 (e113.3)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in lung cancer across different ethnic or ancestral populations, particularly comparing East Asian patients to other populations, including environmental factors, genetic background, and proposed mechanisms for population differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Latin America (CLICaP)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Latin-American consortium CLICaP pooled data (Arrieta et al.)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Large multi-country compilation of EGFR (and KRAS) mutation frequencies in Latin America showing marked heterogeneity across countries; referenced by the Uruguayan authors to contextualize regional variation.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Updated frequency of EGFR and KRAS mutations in nonsmall-cell lung cancer in Latin America: the Latin-American consortium for the investigation of lung cancer (CLICaP).</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>CLICaP pooled dataset of n = 5738 Latin American NSCLC patients (per the paper's description of the Arrieta et al. study).</td>
                        </tr>
                        <tr>
                            <td><strong>population_ancestry</strong></td>
                            <td>Mixed Latin American populations (admixed proportions vary by country: Amerindian, European, African contributions).</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td>Country-level prevalences reported in the pooled study (as quoted in this paper): Argentina 14.4%; Colombia 24.7%; Panama 27.3%; Costa Rica 31.4%; Mexico 34.3%; Peru 51.1% (range across Latin America reported as wide).</td>
                        </tr>
                        <tr>
                            <td><strong>specific_egfr_mutations</strong></td>
                            <td>The paper notes that for some country data only exons 19 and 21 were analyzed; general statement that exon 19 deletions and L858R are the majority but distribution may vary by country; no per-country detailed mutation spectrum in this paper beyond prevalences.</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_smoking_association</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td>Not comprehensively described across the consortium in this paper; authors later suggest that low tobacco consumption in some Caribbean populations may explain higher rates there.</td>
                        </tr>
                        <tr>
                            <td><strong>germline_genetic_factors</strong></td>
                            <td>Authors hypothesize that variable Amerindian/European/African ancestry across Latin American countries contributes to the observed heterogeneity (e.g., high Amerindian ancestry in Peru linked to higher EGFR prevalence).</td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td>Compared within Latin America (country-to-country heterogeneity) and against Asian and European prevalence benchmarks.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Authors propose that differential genomic ancestry (Amerindian contribution especially) and local admixture histories help explain country-to-country prevalence differences across Latin America.</td>
                        </tr>
                        <tr>
                            <td><strong>clinical_characteristics</strong></td>
                            <td>Not uniformly provided across pooled dataset in this paper; Arrieta et al. methods varied by country (some only tested exons 19 and 21, others used ARMS kits), which affects comparability.</td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td>Heterogeneous testing methods across countries (some only exons 19 and 21 by sequencing, some used ARMS kits for known mutations), differing sampling frames, and technical sensitivity differences noted by authors.</td>
                        </tr>
                        <tr>
                            <td><strong>geographic_variation</strong></td>
                            <td>Marked geographic heterogeneity across Latin America with Peru notably high (51.1%) and Argentina lower (~14.4%).</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e113.4">
                <h3 class="extraction-instance">Extracted Data Instance 4 (e113.4)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in lung cancer across different ethnic or ancestral populations, particularly comparing East Asian patients to other populations, including environmental factors, genetic background, and proposed mechanisms for population differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Peru</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Peruvian NSCLC patients (reported prevalence)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Reported high EGFR mutation prevalence within Latin America, which the authors link to high Amerindian ancestry in Peru.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Updated frequency of EGFR and KRAS mutations in nonsmall-cell lung cancer in Latin America: the Latin-American consortium for the investigation of lung cancer (CLICaP).</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>Peruvian patients included in the CLICaP pooled analysis (exact n not given in this paper).</td>
                        </tr>
                        <tr>
                            <td><strong>population_ancestry</strong></td>
                            <td>Peruvian populations with high Amerindian ancestry (cited ranges 76-98% Amerindian, 1-31% European, 1-3% African according to the authors' referenced sources).</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td>Reported as 51.1% (from Arrieta et al. pooled Latin America data).</td>
                        </tr>
                        <tr>
                            <td><strong>specific_egfr_mutations</strong></td>
                            <td>Not detailed by the Uruguayan paper for Peru specifically; general comment that common exon 19 deletions and L858R dominate in many cohorts.</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_smoking_association</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td>Not specified for Peru in this paper.</td>
                        </tr>
                        <tr>
                            <td><strong>germline_genetic_factors</strong></td>
                            <td>Authors posit that the high Amerindian genomic ancestry proportion may underlie the higher EGFR mutation prevalence in Peru.</td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td>Compared implicitly to other Latin American countries and to Asian and European reference prevalences.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Population genetic ancestry (high Amerindian contribution) proposed as a potential explanation for the high EGFR mutation frequency observed in Peru.</td>
                        </tr>
                        <tr>
                            <td><strong>clinical_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td>Pooled-data methodological heterogeneity and potential sampling/testing differences across countries.</td>
                        </tr>
                        <tr>
                            <td><strong>geographic_variation</strong></td>
                            <td>Peru stands out within Latin America as having one of the highest reported EGFR mutation prevalences.</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e113.5">
                <h3 class="extraction-instance">Extracted Data Instance 5 (e113.5)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in lung cancer across different ethnic or ancestral populations, particularly comparing East Asian patients to other populations, including environmental factors, genetic background, and proposed mechanisms for population differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Mexico</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Mexican NSCLC patients (reported prevalence)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Reported EGFR mutation prevalence in Mexico is high within Latin America and is discussed in relation to Mexican Amerindian/European admixture proportions.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Updated frequency of EGFR and KRAS mutations in nonsmall-cell lung cancer in Latin America: the Latin-American consortium for the investigation of lung cancer (CLICaP).</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>Mexican patients in the Arrieta pooled study (exact n not provided in this paper summary).</td>
                        </tr>
                        <tr>
                            <td><strong>population_ancestry</strong></td>
                            <td>Mexican population described as ~51-56% Amerindian, ~40-45% European, ~2-5% African (as cited by authors).</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td>Reported as 34.3% (from Arrieta et al.).</td>
                        </tr>
                        <tr>
                            <td><strong>specific_egfr_mutations</strong></td>
                            <td>Not broken down in this paper for Mexico specifically; general dominance of exon 19 deletions and L858R noted across cohorts.</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_smoking_association</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>germline_genetic_factors</strong></td>
                            <td>Authors suggest proportionally higher Amerindian ancestry in Mexico may contribute to elevated EGFR mutation prevalence relative to Europe.</td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td>Compared to other Latin American countries and to European/Asian benchmarks.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Genetic ancestry (Amerindian admixture) proposed as explanatory factor for higher prevalence.</td>
                        </tr>
                        <tr>
                            <td><strong>clinical_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td>Testing methods varied across countries in the pooled study (affects comparability).</td>
                        </tr>
                        <tr>
                            <td><strong>geographic_variation</strong></td>
                            <td>Mexico shows higher prevalence than some Latin American countries but lower than Peru in the reported pooled data.</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e113.6">
                <h3 class="extraction-instance">Extracted Data Instance 6 (e113.6)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in lung cancer across different ethnic or ancestral populations, particularly comparing East Asian patients to other populations, including environmental factors, genetic background, and proposed mechanisms for population differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Brazil</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Brazilian NSCLC patients (selected studies)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Several Brazilian studies report variable EGFR mutation frequencies (examples cited range ~21.6%â€“24% and one study reported 6.6%), illustrating within-country heterogeneity and potential links to ancestry.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Mutational profile and new IASLC/ATS/ERS classification provide additional prognostic information about lung adenocarcinoma: a study of 125 patients from Brazil.</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>Brazilian cohorts from several studies cited by the authors (e.g., De Melo et al., Carneiro et al.); sizes vary (examples include n=125 in one cited study).</td>
                        </tr>
                        <tr>
                            <td><strong>population_ancestry</strong></td>
                            <td>Brazilian populations are admixed with variable European, African, and Amerindian contributions; some studies evaluated ancestry and found higher African component in certain lung cancer cases.</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td>Reported ranges in the text: ~24% in some adenocarcinoma series, De Melo et al. reported 21.6%; another study (Carneiro et al.) reported 6.6%.</td>
                        </tr>
                        <tr>
                            <td><strong>specific_egfr_mutations</strong></td>
                            <td>One Brazilian study noted a high proportion of rare mutations with common exon 19/21 alterations representing ~40% of mutations in that series; exact per-study spectra vary.</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_smoking_association</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>germline_genetic_factors</strong></td>
                            <td>Some Brazilian work evaluated ancestry and noted differential African ancestry prevalence among lung cancer cases versus controls, suggesting ancestry-related genetic effects may influence mutation spectra and frequency.</td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td>Authors contrast Brazilian variability with other Latin American countries and global benchmarks.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Authors imply admixture and ancestry differences may explain within-country variability (e.g., higher African ancestry correlating with lower EGFR mutation frequency in one report).</td>
                        </tr>
                        <tr>
                            <td><strong>clinical_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td>Inter-study differences in detection methods, sample sizes, and ancestry composition may account for heterogeneity.</td>
                        </tr>
                        <tr>
                            <td><strong>geographic_variation</strong></td>
                            <td>Within Brazil, different cohorts show different frequencies, supporting geographic/ancestral heterogeneity.</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e113.7">
                <h3 class="extraction-instance">Extracted Data Instance 7 (e113.7)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in lung cancer across different ethnic or ancestral populations, particularly comparing East Asian patients to other populations, including environmental factors, genetic background, and proposed mechanisms for population differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>African / African-descendent</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>African and African-descendent (African American, Caribbean) NSCLC patients</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Data from African and African-descendent populations are limited and conflicting; early small studies reported very low EGFR frequencies while others report higher rates, with reviews highlighting methodological and population-bias explanations.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>EGFR molecular testing in African-American non-small cell lung cancer patients-a review of discrepant data.</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>Heterogeneous small cohorts of African-origin or African-descendent patients (including African Americans and Caribbean populations) from several cited reports and reviews; exact sizes vary across referenced studies.</td>
                        </tr>
                        <tr>
                            <td><strong>population_ancestry</strong></td>
                            <td>Self-identified African ancestry, African American, and Caribbean African-descendent groups (heterogeneous).</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td>Conflicting reports cited: as low as 2% in an early report, other studies reported ~12% and ~19%; Leduc et al. reported 36% in a Caribbean cohort (mostly African-descent).</td>
                        </tr>
                        <tr>
                            <td><strong>specific_egfr_mutations</strong></td>
                            <td>Not consistently detailed in this paper for African cohorts; referenced studies report variable spectra.</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status</strong></td>
                            <td>In at least one Caribbean report higher mutation frequency was ascribed in part to low tobacco consumption in that population (authors cite environmental/behavioral factor).</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_smoking_association</strong></td>
                            <td>Authors note that lower tobacco consumption was hypothesized to explain higher observed EGFR mutation frequency in a Caribbean cohort; otherwise associations not systematically reported in this paper.</td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td>Low tobacco consumption in the Caribbean cohort is cited as a possible environmental explanation for higher EGFR rates in that population.</td>
                        </tr>
                        <tr>
                            <td><strong>germline_genetic_factors</strong></td>
                            <td>Authors note that ancestry estimation and self-reporting inconsistencies, plus admixture, complicate inference; no specific germline variants are identified as causal in African populations in this paper.</td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td>African-descendent cohorts are contrasted with Asian and Caucasian prevalence benchmarks; reported values are highly variable and debated.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Authors and cited reviewers propose multiple explanations for discrepant African-data: sampling bias (sex, smoker status), self-reported ethnicity inaccuracies, assay sensitivity disparities, and statistical artifacts (Simpson's paradox) rather than a single clear genetic mechanism.</td>
                        </tr>
                        <tr>
                            <td><strong>clinical_characteristics</strong></td>
                            <td>Not systematically reported in this paper; referenced studies vary in design and reporting.</td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td>Population bias, small sample sizes, heterogeneity in mutation detection methods, self-reported ethnicity, and statistical confounding (Simpson's paradox) are explicitly discussed.</td>
                        </tr>
                        <tr>
                            <td><strong>geographic_variation</strong></td>
                            <td>Paper highlights heterogeneity between African-American cohorts and Caribbean cohorts, with some Caribbean data unexpectedly high compared with earlier African-American reports.</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e113.8">
                <h3 class="extraction-instance">Extracted Data Instance 8 (e113.8)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in lung cancer across different ethnic or ancestral populations, particularly comparing East Asian patients to other populations, including environmental factors, genetic background, and proposed mechanisms for population differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Amerindian ancestry (proposed factor)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Native American / Amerindian ancestral genomic contribution</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Authors propose that the proportion of Native American (Amerindian) ancestry in admixed Latin American populations correlates with higher EGFR mutation prevalence observed in some countries (e.g., Peru, Mexico).</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>Admixture in Latin America: geographic structure, phenotypic diversity and self-perception of ancestry based on 7,342 individuals.</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>Population-level ancestry estimates in Latin American countries from published admixture studies (e.g., Peru, Mexico) cited by the authors to contextualize EGFR prevalence differences.</td>
                        </tr>
                        <tr>
                            <td><strong>population_ancestry</strong></td>
                            <td>Amerindian (Native American) ancestral component within admixed Latin American populations.</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td>Not a direct measure for Amerindian individuals; authors correlate country-level Amerindian ancestry proportions (e.g., Peru 76-98%; Mexico 51-56%) with higher reported EGFR mutation prevalences (e.g., Peru 51.1%, Mexico 34.3%).</td>
                        </tr>
                        <tr>
                            <td><strong>specific_egfr_mutations</strong></td>
                            <td>Not specified at the Amerindian-ancestry level in this paper.</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_smoking_association</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>germline_genetic_factors</strong></td>
                            <td>Amerindian ancestral genomic background is proposed as a population-genetic contributor to higher somatic EGFR mutation prevalence, but no specific germline causal variants are identified in this paper.</td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td>Amerindian-rich populations (Peru, parts of Mexico) compared qualitatively with predominantly European-ancestry populations (e.g., Uruguay, Europe) and East Asians.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Authors propose genetic susceptibility linked to ancestral genomic background (Amerindian ancestry) as a plausible mechanism explaining higher EGFR mutation frequencies in some Latin American populations.</td>
                        </tr>
                        <tr>
                            <td><strong>clinical_characteristics</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td>Admixture complexity, regional variation, and differences in testing approaches could confound correlations between ancestry proportions and mutation prevalence.</td>
                        </tr>
                        <tr>
                            <td><strong>geographic_variation</strong></td>
                            <td>Regional differences within Latin America (higher EGFR prevalence in countries with greater Amerindian ancestry).</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e113.9">
                <h3 class="extraction-instance">Extracted Data Instance 9 (e113.9)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of EGFR mutation frequencies in lung cancer across different ethnic or ancestral populations, particularly comparing East Asian patients to other populations, including environmental factors, genetic background, and proposed mechanisms for population differences.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Q787Q polymorphism</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>EGFR c.2361G>A (p.Q787Q) silent polymorphism</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>A synonymous EGFR variant (c.2361G>A, p.Q787Q, rs1050171) observed at differing allele frequencies across populations and analyzed in the Uruguayan cohort for association with common activating EGFR mutations.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>here</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>study_population</strong></td>
                            <td>Sequenced subset of the Uruguayan cohort (exon 20 successfully sequenced in 273 cases) with reported allele frequencies; comparisons to 1000 Genomes Latin American, Asian, and European frequencies are made.</td>
                        </tr>
                        <tr>
                            <td><strong>population_ancestry</strong></td>
                            <td>Observed in admixed Latin American samples; population allele frequency compared to Asian and European reference populations.</td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_frequency</strong></td>
                            <td>Not applicable (polymorphism frequency reported): G allele frequency ~0.405 in Uruguayan cohort (paper reports allele G = 0.405 and Hardy-Weinberg p = 0.139).</td>
                        </tr>
                        <tr>
                            <td><strong>specific_egfr_mutations</strong></td>
                            <td>Authors tested for association between c.2361G>A and main EGFR activating mutations (L858R and exon 19 deletions) and found no significant association in their sample.</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_status</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>egfr_mutation_smoking_association</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>environmental_factors</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>germline_genetic_factors</strong></td>
                            <td>This is a germline synonymous SNP; the paper discusses its differing allele frequencies across populations (higher in Asians per public databases) and considers but does not find an association with common EGFR driver mutations in their cohort.</td>
                        </tr>
                        <tr>
                            <td><strong>comparison_populations</strong></td>
                            <td>Compared allele frequencies with 1000 Genomes admixed Latin American groups (Colombia, Peru, Mexico, Puerto Rico), Asians (higher frequency ~82% per db), and Europeans (~39% per db).</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanism</strong></td>
                            <td>Authors suggest that population-level differences in such polymorphisms may relate to geographic/ancestral susceptibility patterns of EGFR mutations, but no mechanistic role is established in this study.</td>
                        </tr>
                        <tr>
                            <td><strong>clinical_characteristics</strong></td>
                            <td>Not linked to clinical phenotype in this cohort; other cited papers suggest possible prognostic associations in some contexts but not demonstrated here.</td>
                        </tr>
                        <tr>
                            <td><strong>confounding_factors</strong></td>
                            <td>Small numbers and admixture structure complicate interpretation; association tests in this cohort were negative.</td>
                        </tr>
                        <tr>
                            <td><strong>geographic_variation</strong></td>
                            <td>Allele frequency varies by population: higher in Asians, intermediate in admixed Latin Americans, lower in Europeans per referenced population databases.</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>

        <div class="section">
            <h2>Potentially Relevant New Papers (mentioned by this paper)</h2>
            <ol>
                <li>The international association for the study of lung cancer consensus statement on optimizing management of EGFR mutation-positive non-small cell lung cancer: status in 2016. <em>(Rating: 2)</em></li>
                <li>Updated frequency of EGFR and KRAS mutations in nonsmall-cell lung cancer in Latin America: the Latin-American consortium for the investigation of lung cancer (CLICaP). <em>(Rating: 2)</em></li>
                <li>EGFR molecular testing in African-American non-small cell lung cancer patients-a review of discrepant data. <em>(Rating: 2)</em></li>
                <li>Incidence of lung adenocarcinoma biomarker in a Caribbean and African caribbean population. <em>(Rating: 2)</em></li>
                <li>Genetic abnormalities of the EGFR pathway in African American patients with nonsmall-cell lung cancer. <em>(Rating: 1)</em></li>
                <li>Frequency and type of epidermal growth factor receptor mutations in African Americans with non-small cell lung cancer. <em>(Rating: 1)</em></li>
                <li>Mutational profile and new IASLC/ATS/ERS classification provide additional prognostic information about lung adenocarcinoma: a study of 125 patients from Brazil. <em>(Rating: 1)</em></li>
                <li>Spectrum of somatic EGFR, KRAS, BRAF, PTEN mutations and TTF-1 expression in Brazilian lung cancer patients. <em>(Rating: 1)</em></li>
                <li>Admixture in Latin America: geographic structure, phenotypic diversity and self-perception of ancestry based on 7,342 individuals. <em>(Rating: 2)</em></li>
                <li>EGFR exon mutation distribution and outcome in non-small-cell lung cancer: a Portuguese retrospective study. <em>(Rating: 1)</em></li>
            </ol>
        </div>

        </div>

    </div>
</body>
</html>